Investing Profile

Paul Berns

InvestorVC
Managing Director at ARCH Venture Partners
Photo of Paul Berns, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$25.0M
19
$635.8M
CompanyStageDateRound SizeTotal Raised
Salma Health
Series AFeb 2026$80M
$80M
Co-investors: Alaa Halawa (Mubadala)
Elephas
Series UnknownNov 2025$40M
Series CJan 2024$55M
Series BSep 2022$42M
$140M
Kardigan
Series BOct 2025$250M
Series AJan 2025$300M
$550M
Ollin Biosciences
Series ASep 2025$100M
$100M
Co-investors: Alaa Halawa (Mubadala)
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Kristina Burow (ARCH Venture Partners), Alaa Halawa (Mubadala)
Metsera
Series BNov 2024$220M
Series AApr 2024$290M
$510M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Nimish Shah (Venrock), Kristina Burow (ARCH Venture Partners)
Matter Neuroscience
SeedFeb 2024$26M
$26M
Co-investors: Amir Nashat (Polaris Venture Partners)
Areteia Therapeutics
Series AFeb 2024$75M
Series AJul 2022$350M
$430M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Adam Koppel (Bain Capital Life Sciences)